This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Axcelis Technologies (ACLS) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
ACLSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Unity Software Inc. (U) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
UPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Palantir Technologies Inc. (PLTR) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
PLTRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Kennametal (KMT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
KMTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Axcelis Technologies (ACLS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
ACLSNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Pebblebrook Hotel (PEB) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
PEBNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Akamai Technologies (AKAM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
AKAMNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Akamai Technologies (AKAM) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
AKAMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Pebblebrook Hotel (PEB) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
PEBNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Petrobras (PBR) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
PBRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Atara Biotherapeutics (ATRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ATRANegative Net Change CRVONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Caleres Inc. (CAL): Can Its 9.4% Jump Turn into More Strength?
by Zacks Equity Research
Caleres Inc. (CAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CALPositive Net Change NKEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Kohl's (KSS) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
KSSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Sonida Senior Living (SNDA) Soars 14.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sonida Senior Living (SNDA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SNDANegative Net Change AUNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
IDXXNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
IDXXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Knot Offshore (KNOP) Soars 9.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Knot Offshore (KNOP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
KNOPPositive Net Change ECONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Amazon (AMZN) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
AMZNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Clene (CLNN) Stock Jumps 25.0%: Will It Continue to Soar?
by Zacks Equity Research
Clene (CLNN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CLNNNegative Net Change GLUENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Brighthouse Financial (BHF) Surges 24.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Brighthouse Financial (BHF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BHFPositive Net Change SLFNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Day One Biopharmaceuticals (DAWN) Soars 5.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Day One Biopharmaceuticals (DAWN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
DAWNNegative Net Change ATRANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Keysight (KEYS) Moves 4.3% Higher: Will This Strength Last?
by Zacks Equity Research
Keysight (KEYS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
KEYSNegative Net Change CAMTPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Allbirds, Inc. (BIRD): Can Its 12.6% Jump Turn into More Strength?
by Zacks Equity Research
Allbirds, Inc. (BIRD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BIRDPositive Net Change ANFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength?
by Zacks Equity Research
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MRNANegative Net Change SEPNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CSG Systems (CSGS) Stock Jumps 14.4%: Will It Continue to Soar?
by Zacks Equity Research
CSG Systems (CSGS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
CSGSNegative Net Change GIBNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today